{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:11Z","timestamp":1787242271728,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002706","name":"AFA Insurance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Albert Pa\u030ahlsson and Gunnar Nilsson Foundations"},{"name":"Malmo\u0308 city council"},{"name":"Swedish Diabetes Foundation"},{"name":"the Regional Agreement on Medical Training and Clinical Research (ALF) between Region Sk\u00e5ne and Lund University"},{"name":"Stig and Ragna Gorthons foundation"},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dupuytren\u2019s disease (DD) is a fibroproliferative disorder affecting the palmar fascia of the hand. Risk factors include diabetes mellitus (DM), whereas a high body mass index (BMI) is associated with a lower prevalence of DD. The aim of this study was to further elucidate risk and protective factors for the development of DD using longitudinal population-based data from the Malm\u00f6 Diet and Cancer Study (MDCS). During 1991\u20131996, the inhabitants aged 46\u201373\u00a0years in the city of Malm\u00f6, Sweden were invited to participate in the population-based MDCS (41% participation rate). Data on incident DD were retrieved from Swedish national registers. Associations between DM, alcohol consumption, BMI, and serum apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) at baseline were analysed in multivariable Cox regression models adjusted for known confounders. Among 30,446 recruited participants, 347 men and 194 women were diagnosed with DD during a median follow-up time of 23\u00a0years. DM (men HR 2.23; 95% CI 1.50\u20133.30, women HR 2.69; 95% CI 1.48\u20134.90) and alcohol consumption (men HR 2.46; 95% CI 1.85\u20133.27, women HR 3.56; 95% CI 1.95\u20136.50) were independently associated with incident DD in the Cox regression models. Furthermore, inverse associations with incident DD were found for obesity among men, and ApoB\/ApoA1 ratio among both sexes. DM and excess alcohol consumption constituted major risk factors for the development of DD. Furthermore, an inverse association between obesity among men and DD, and also between ApoB\/ApoA1 ratio and DD was found in both sexes.<\/jats:p>","DOI":"10.1038\/s41598-021-94025-7","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T06:03:18Z","timestamp":1626674598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Metabolic factors and the risk of Dupuytren\u2019s disease: data from 30,000 individuals followed for over 20\u00a0years"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-8660","authenticated-orcid":false,"given":"Mattias","family":"Rydberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Persson","family":"L\u00f6fgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gotts\u00e4ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars B.","family":"Dahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"94025_CR1","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jcot.2020.03.026","volume":"11","author":"A Dutta","year":"2020","unstructured":"Dutta, A. et al. Dupuytren\u2019s contracture\u2014Current concepts. J. Clin. Orthop. Trauma 11, 590\u2013596 (2020).","journal-title":"J. Clin. Orthop. Trauma"},{"key":"94025_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.prs.0000438455.37604.0f","volume":"133","author":"R Lanting","year":"2014","unstructured":"Lanting, R., Broekstra, D. C., Werker, P. M. & van den Heuvel, E. R. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast. Reconstr. Surg. 133, 593\u2013603 (2014).","journal-title":"Plast. Reconstr. Surg."},{"key":"94025_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","volume":"4","author":"S Hindocha","year":"2009","unstructured":"Hindocha, S., McGrouther, D. A. & Bayat, A. Epidemiological evaluation of Dupuytren\u2019s disease incidence and prevalence rates in relation to etiology. Hand (N. Y.) 4, 256\u2013269 (2009).","journal-title":"Hand (N. Y.)"},{"key":"94025_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1753193416687914","volume":"42","author":"J Nordenskjold","year":"2017","unstructured":"Nordenskjold, J., Englund, M., Zhou, C. & Atroshi, I. Prevalence and incidence of doctor-diagnosed Dupuytren\u2019s disease: A population-based study. J. Hand Surg. Eur. 42, 673\u2013677 (2017).","journal-title":"J. Hand Surg. Eur."},{"key":"94025_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jclinepi.2003.11.015","volume":"57","author":"NS Godtfredsen","year":"2004","unstructured":"Godtfredsen, N. S., Lucht, H., Prescott, E., S\u00f8rensen, T. I. & Gr\u00f8nbaek, M. A prospective study linked both alcohol and tobacco to Dupuytren\u2019s disease. J. Clin. Epidemiol. 57, 858\u2013863 (2004).","journal-title":"J. Clin. Epidemiol."},{"key":"94025_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004214","volume":"4","author":"A Descatha","year":"2014","unstructured":"Descatha, A. et al. Association among work exposure, alcohol intake, smoking and Dupuytren\u2019s disease in a large cohort study (GAZEL). BMJ Open 4, e004214 (2014).","journal-title":"BMJ Open"},{"key":"94025_CR7","first-page":"643","volume":"82","author":"V Wijnen","year":"2016","unstructured":"Wijnen, V., Buntinx, F., De Smet, L., Bartholomeeusen, S. & Degreef, I. Comorbidity in Dupuytren disease. Acta Orthop. Belg. 82, 643\u2013648 (2016).","journal-title":"Acta Orthop. Belg."},{"key":"94025_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0072-968X(78)80019-9","volume":"10","author":"OA Mikkelsen","year":"1978","unstructured":"Mikkelsen, O. A. Dupuytren\u2019s disease\u2014The influence of occupation and previous hand injuries. Hand 10, 1\u20138 (1978).","journal-title":"Hand"},{"key":"94025_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1753193414535720","volume":"40","author":"S Larsen","year":"2014","unstructured":"Larsen, S. et al. Genetic and environmental influences in Dupuytren\u2019s disease: A study of 30,330 Danish twin pairs. J. Hand Surg. (Eur. Vol.) 40, 171\u2013176 (2014).","journal-title":"J. Hand Surg. (Eur. Vol.)"},{"key":"94025_CR10","doi-asserted-by":"publisher","first-page":"367e","DOI":"10.1097\/PRS.0000000000004120","volume":"141","author":"DC Broekstra","year":"2018","unstructured":"Broekstra, D. C., Groen, H., Molenkamp, S., Werker, P. M. N. & van den Heuvel, E. R. A systematic review and meta-analysis on the strength and consistency of the associations between Dupuytren disease and diabetes mellitus, liver disease, and epilepsy. Plast. Reconstr. Surg. 141, 367e\u2013379e (2018).","journal-title":"Plast. Reconstr. Surg."},{"key":"94025_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhsa.2016.12.010","volume":"42","author":"JH Hacquebord","year":"2017","unstructured":"Hacquebord, J. H., Chiu, V. Y. & Harness, N. G. The risk of Dupuytren diagnosis in obese individuals. J. Hand Surg. 42, 149\u2013155 (2017).","journal-title":"J. Hand Surg."},{"key":"94025_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0895-4356(99)00145-6","volume":"53","author":"KG Gudmundsson","year":"2000","unstructured":"Gudmundsson, K. G., Arngrmsson, R., Sigf\u00fasson, N., Bj\u00f6rnsson, \u00c1. & J\u00f3nsson, T. Epidemiology of Dupuytren\u2019s disease: Clinical, serological, and social assessment. The Reykjavik Study. J. Clin. Epidemiol. 53, 291\u2013296 (2000).","journal-title":"J. Clin. Epidemiol."},{"key":"94025_CR13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/gepi.22209","volume":"43","author":"M Major","year":"2019","unstructured":"Major, M. et al. Integrative analysis of Dupuytren\u2019s disease identifies novel risk locus and reveals a shared genetic etiology with BMI. Genet. Epidemiol. 43, 629\u2013645 (2019).","journal-title":"Genet. Epidemiol."},{"key":"94025_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1302\/0301-620X.74B6.1447259","volume":"74","author":"PL Sanderson","year":"1992","unstructured":"Sanderson, P. L., Morris, M. A., Stanley, J. K. & Fahmy, N. R. Lipids and Dupuytren\u2019s disease. J. Bone Jt. Surg. Br. 74, 923\u2013927 (1992).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"94025_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF02537234","volume":"18","author":"JL Rabinowitz","year":"1983","unstructured":"Rabinowitz, J. L., Ostermann, L., Bora, F. W. & Staeffen, J. Lipid composition and de novo lipid biosynthesis of human palmar fat in Dupuytren\u2019s disease. Lipids 18, 371\u2013374 (1983).","journal-title":"Lipids"},{"key":"94025_CR16","first-page":"216","volume":"68","author":"JH Hacquebord","year":"2017","unstructured":"Hacquebord, J. H. & Harness, N. G. The relationship of normal BMI and Dupuytren\u2019s disease. Minerva Ortopedica e Traumatologica 68, 216\u2013219 (2017).","journal-title":"Minerva Ortopedica e Traumatologica"},{"key":"94025_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2796.1993.tb00647.x","volume":"233","author":"G Berglund","year":"1993","unstructured":"Berglund, G., Elmstahl, S., Janzon, L. & Larsson, S. A. The Malmo diet and cancer study. Design and feasibility. J. Intern. Med. 233, 45\u201351 (1993).","journal-title":"J. Intern. Med."},{"key":"94025_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jc.2007-1817","volume":"93","author":"SY Goh","year":"2008","unstructured":"Goh, S. Y. & Cooper, M. E. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 93, 1143\u20131152 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94025_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","volume":"19","author":"VL Bodiga","year":"2014","unstructured":"Bodiga, V. L., Eda, S. R. & Bodiga, S. Advanced glycation end products: Role in pathology of diabetic cardiomyopathy. Heart Fail. Rev. 19, 49\u201363 (2014).","journal-title":"Heart Fail. Rev."},{"key":"94025_CR20","first-page":"221","volume":"7","author":"SY Kyung","year":"2013","unstructured":"Kyung, S. Y. et al. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP. Int. J. Clin. Exp. Pathol. 7, 221\u2013228 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"94025_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1932296814525030","volume":"8","author":"J Sessions","year":"2014","unstructured":"Sessions, J. & Nickerson, D. S. Biologic basis of nerve decompression surgery for focal entrapments in diabetic peripheral neuropathy. J. Diabetes Sci. Technol. 8, 412\u2013418 (2014).","journal-title":"J. Diabetes Sci. Technol."},{"key":"94025_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13018-018-0848-4","volume":"13","author":"F Takase","year":"2018","unstructured":"Takase, F. et al. Association of advanced glycation end products in Dupuytren disease. J. Orthop Surg. Res. 13, 143 (2018).","journal-title":"J. Orthop Surg. Res."},{"key":"94025_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.matbio.2010.04.004","volume":"29","author":"A Yuen","year":"2010","unstructured":"Yuen, A. et al. Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol. 29, 537\u2013548 (2010).","journal-title":"Matrix Biol."},{"key":"94025_CR24","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1038\/jid.2013.219","volume":"133","author":"JSN Verhoekx","year":"2013","unstructured":"Verhoekx, J. S. N. et al. Isometric contraction of Dupuytren\u2019s myofibroblasts is inhibited by blocking intercellular junctions. J. Investig. Dermatol. 133, 2664\u20132671 (2013).","journal-title":"J. Investig. Dermatol."},{"key":"94025_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jdiacomp.2008.12.009","volume":"24","author":"N Papanas","year":"2010","unstructured":"Papanas, N. & Maltezos, E. The diabetic hand: A forgotten complication?. J. Diabetes Complicat. 24, 154\u2013162 (2010).","journal-title":"J. Diabetes Complicat."},{"key":"94025_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001298","volume":"8","author":"M Rydberg","year":"2020","unstructured":"Rydberg, M. et al. Diabetes mellitus as a risk factor for compression neuropathy: A longitudinal cohort study from southern Sweden. BMJ Open Diabetes Res. Care 8, e001298 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"94025_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000002740","volume":"8","author":"M Zimmerman","year":"2020","unstructured":"Zimmerman, M. et al. Ulnar nerve entrapment in diabetes: Patient-reported Outcome after Surgery in National Quality Registries. Plast. Reconstr. Surg. Glob. Open 8, e2740 (2020).","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"94025_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","volume":"391","author":"AM Wood","year":"2018","unstructured":"Wood, A. M. et al. Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513\u20131523 (2018).","journal-title":"Lancet"},{"key":"94025_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/add.13341","volume":"111","author":"A Kalinowski","year":"2016","unstructured":"Kalinowski, A. & Humphreys, K. Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. Addiction 111, 1293\u20131298 (2016).","journal-title":"Addiction"},{"key":"94025_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/oemed-2011-100319","volume":"69","author":"A Descatha","year":"2012","unstructured":"Descatha, A. et al. Heavy manual work, exposure to vibration and Dupuytren\u2019s disease? Results of a surveillance program for musculoskeletal disorders. Occup. Environ. Med. 69, 296\u2013299 (2012).","journal-title":"Occup. Environ. Med."},{"key":"94025_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/1753193420958553","volume":"46","author":"M Majeed","year":"2020","unstructured":"Majeed, M., Wiberg, A., Ng, M., Holmes, M. V. & Furniss, D. The relationship between body mass index and the risk of development of Dupuytren\u2019s disease: a Mendelian randomization study. J. Hand Surg. (Eur. Vol.) 46, 406\u2013410 (2020).","journal-title":"J. Hand Surg. (Eur. Vol.)"},{"key":"94025_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","volume":"259","author":"G Walldius","year":"2006","unstructured":"Walldius, G. & Jungner, I. The apoB\/apoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2014A review of the evidence. J. Intern. Med. 259, 493\u2013519 (2006).","journal-title":"J. Intern. Med."},{"key":"94025_CR33","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.2174\/1381612820666140620121828","volume":"20","author":"C Schmidt","year":"2014","unstructured":"Schmidt, C. & Bergstrom, G. Apolipoprotein B and apolipopotein A-I in vascular risk prediction\u2014A review. Curr. Pharm. Des. 20, 6289\u20136298 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"94025_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur. Heart J. 41, 111\u2013188 (2020).","journal-title":"Eur. Heart J."},{"key":"94025_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/cge.12410","volume":"87","author":"K Becker","year":"2015","unstructured":"Becker, K. et al. The importance of genetic susceptibility in Dupuytren\u2019s disease. Clin. Genet. 87, 483\u2013487 (2015).","journal-title":"Clin. Genet."},{"key":"94025_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","volume":"169","author":"S Enh\u00f6rning","year":"2015","unstructured":"Enh\u00f6rning, S., Hedblad, B., Nilsson, P. M., Engstr\u00f6m, G. & Melander, O. Copeptin is an independent predictor of diabetic heart disease and death. Am. Heart J. 169, 549-556.e541 (2015).","journal-title":"Am. Heart J."},{"key":"94025_CR37","unstructured":"Statistics_Sweden. Occupations in Population and Housing Census 1985 (FoB 85) According to Nordic Standard Occupational Classification (Nordisk yrkesklassificering NYK) and Swedish Socio-economic Classification (Socioekonomisk indelning SEI) (Statistics Sweden, 1989)."},{"key":"94025_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/14034948020300020401","volume":"30","author":"J Manjer","year":"2002","unstructured":"Manjer, J., Elmst\u00e5hl, S., Janzon, L. & Berglund, G. Invitation to a population-based cohort study: Differences between subjects recruited using various strategies. Scand. J. Public Health 30, 103\u2013112 (2002).","journal-title":"Scand. J. Public Health"},{"key":"94025_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson, J. F. et al. External review and validation of the Swedish national inpatient register. BMC Public Health 11, 450\u2013450 (2011).","journal-title":"BMC Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94025-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T01:18:24Z","timestamp":1699233504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94025"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94025-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14669"}}